IP Library Granted Patent US 8,206,949
Granted Patent B2
US 8,206,949 · App. 12/084,591 · Granted Jun 26, 2012

Production of glycoproteins with reduced O-glycosylation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,949
App. No.
12/084,591
Granted
Jun 26, 2012
Kind
B2
Abstract

A method is described for producing protein compositions having reduced amounts of O-linked glycosylation. The method includes producing the protein in cells cultured in the presence of an inhibitor of Pmt-mediated O-linked glycosylation and/or in the presence of one or more α-1,2-mannosidases.

Claims (23)

1. A method of producing a protein having reduced O-linked glycosylation comprising:

(a) providing a nucleic acid encoding a protein operably linked to an inducible promoter;

(b) introducing the nucleic acid into a yeast host cell or filamentous fungal host cell to provide a culture of the host cell;

(c) growing the culture for a time sufficient to provide a multiplicity of the host cells having the nucleic acid before contacting the culture with one or more inhibitors of Pmt-mediated O-linked glycosylation;

(d) contacting the culture with an inducer of the promoter to induce expression of the protein at a time before or at the same time as contacting the culture with the one or more inhibitors of Pmt-mediated O-linked glycosylation; and

(e) isolating the glycoprotein produced by the host cell in the presence of the one or more inhibitors to produce the protein having reduced O-linked glycosylation.

2. The method of claim 1 wherein the one or more inhibitors is a benzylidene thiazolidinedione.

3. The method of claim 2 wherein the one or more inhibitors are selected from the group consisting of: 5-[[3,4-bis(phenylmethoxy)phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid; 5-[[3-(1-Phenylethoxy)-4-(2-phenylethoxy)]phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid; and 5-[[3-(1-Penyl-2-hydroxy)ethoxy)-4-(2-phenylethoxy)]phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid.

4. The method of claim 1 , wherein the host cell [is a yeast or filamentous fungal cell that] has been genetically modified to produce glycoproteins with a predominant N-glycan glycoform.

5. A method of producing a protein having reduced O-linked glycosylation comprising:

(a) providing a nucleic acid encoding a protein operably linked to an inducible promoter;

(b) introducing the nucleic acid into a yeast host cell or filamentous fungal host cell and growing the host cell containing the nucleic acid to produce a culture of the host cell for a time sufficient to provide a multiplicity of the host cells having the nucleic acid before contacting the culture with one or more inhibitors of Pmt-mediated O-linked glycosylation;

(c) contacting the culture with [with one or both of]: (i) one or more inhibitors of Pmt-mediated O-linked glycosylation and optionally with (ii) one or more [one or more] of α-1,2-mannosidase enzymes; and

(d) isolating the glycoprotein produced by the host cell in the presence of the one or more inhibitors and the one or more [one or more] optional α-1,2-mannosidase enzymes to produce the protein having reduced O-linked glycosylation.

6. The method of claim 5 wherein the culture is grown in the presence of the one or more inhibitors of Pmt-mediated O-linked glycosylation.

7. The method of claim 5 wherein a second nucleic acid encoding the one or more α-1,2-mannosidase enzymes is provided and [introducing] the second nucleic acid is introduced into the host cell.

8. The method of claim 5 wherein the one or more inhibitors is a benzylidene thiazolidinedione.

9. The method of claim 5 wherein the one or more inhibitors are selected from the group consisting of: 5-[[3,4-bis(phenylmethoxy)phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid; 5-[[3-(1-Phenylethoxy)-4-(2-phenylethoxy)]phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid; and 5-[[3-(1-Phenyl-2-hydroxy)ethoxy)-4-(2-phenylethoxy)]phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic Acid.

10. The method of claim 5 wherein the α-1,2-mannosidase is from Trichoderma reesei, Saccharomyces sp., or Aspergillus sp.

11. The method of claim 5 wherein the α-1,2-mannosidase is from Trichoderma reesei.

12. The method of claim 5 wherein the host cell includes a second nucleic acid, which encodes the α-1,2-mannosidase, operably linked to an inducible promoter.

13. The method of claim 5 , wherein the host cell is selected from the group consisting of K. lactis, Pichia pastoris, Pichia methanolica , and Hansenula.

14. The method of claim 5 , wherein the host cell [is a yeast or filamentous fungal cell that] has been genetically modified to produce glycoproteins with a predominant N-glycan glycoform.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 021780 FRAME 0730. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE IS GLYCOFI, INC.. Recorded May 15, 2012
From: BOBROWICZ, PIOTR; COOK, W. JAMES; KETT, WARREN
To: GLYCOFI, INC.
Reel/Frame 028214/0069 →
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023906/0803 →